Innate immunity and intracellular trafficking: Insights for novel anti-HIV-1 therapeutics

Current Pharmacogenomics

Volumn 3, Issue 2, 2005, Pages 97-117

  Jones, Kate L ^a,b   Mak, Johnson ^a,b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

APOBEC; ESCRT; Fv1; Hypermutation; Late domain; Lentivirus; Lv1; MVB; Ref1; Restriction; Trim5 ; Vif; VPS

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CELL PROTEIN; CYCLOPHILIN A; CYTIDINE DEAMINASE; CYTOPLASM PROTEIN; GAG PROTEIN; NUCLEIC ACID; RNA; STRUCTURAL PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CELL VACUOLE; DRUG RESEARCH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; MONKEY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN TARGETING; RETROVIRUS; REVIEW; RNA EDITING; SPECIES DIFFERENCE; UBIQUITINATION; VIRION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MAMMALIA;

EID: 20744433063     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160054022962     Document Type: Review

References (235)

1. Alce, T. M. and Popik, W. (2004) APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J. Biol. Chem. 279, 34083-34086.
2. Amit, I.; Yakir, L.; Katz, M.; Zwang, Y.; Marmor, M. D.; Citri, A.; Shtiegman, K.; Alroy, I.; Tuvia, S.; Reiss, Y.; Roubini, E.; Cohen, M.; Wides, R.; Bacharach, E.; Schubert, U. and Yarden, Y. (2004) Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. Genes Dev. 18, 1737-1752.
3. Avela, K.; Lipsanen-Nyman, M.; Idanheimo, N.; Seemanova, E.; Rosengren, S.; Makela, T. P.; Perheentupa, J.; Chapelle, A. D. and Lehesjoki, A. E. (2000) Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat. Genet. 25, 298-301.
4. Babst, M.; Katzmann, D. J.; Estepa-Sabal, E. J.; Meerloo, T. and Emr, S. D. (2002) Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev. Cell 3, 271-282.
5. Babst, M.; Wendland, B.; Estepa, E. J. and Emr, S. D. (1998) The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. Embo J. 17, 2982-2993.
6. Bache, K. G.; Brech, A.; Mehlum, A. and Stenmark, H. (2003a) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol. 162, 435-442.
7. Bache, K. G.; Raiborg, C.; Mehlum, A. and Stenmark, H. (2003b) STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J. Biol. Chem. 278, 12513-12521.
8. Bache, K. G.; Slagsvold, T.; Cabezas, A.; Rosendal, K. R.; Raiborg, C. and Stenmark, H. (2004) The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-1 and mediates receptor down-regulation. Mol. Biol. Cell 15, 4337-4346.
9. Bassin, R. H.; Duran-Troise, G.; Gerwin, B. I. and Rein, A. (1978) Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. J. Virol. 26, 306-315.
10. Begum, N. A.; Kinoshita, K.; Kakazu, N.; Muramatsu, M.; Nagaoka, H.; Shinkura, R.; Biniszkiewicz, D.; Boyer, L. A.; Jaenisch, R. and Honjo, T. (2004) Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305, 1160-1163.
11. Behringer, R. R. and Dewey, M. J. (1985) Cellular site and mode of Fv-2 gene action. Cell 40, 441-447.
12. Benit, L.; De Parseval, N.; Casella, J. F.; Callebaut, I.; Cordonnier, A. and Heidmann, T. (1997) Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J. Virol. 71, 5652-5657.
13. Berkhout, B.; Grigoriev, A.; Bakker, M. and Lukashov, V. V. (2002) Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res. Hum. Retroviruses 18, 133-141.
14. Berthoux, L.; Sebastian, S.; Sokolskaja, E. and Luban, J. (2004) Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J. Virol. 78, 11739-11750.
15. Berthoux, L.; Towers, G. J.; Gurer, C.; Salomoni. P.; Pandolfi, P. P. and Luban, J. (2003) As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 77, 3167-3180.
16. Besnier, C.; Takeuchi, Y. and Towers, G. (2002) Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99, 11920-11925.
17. Best, S.; Le Tissier, P.; Towers, G. and Stoyle, J. P. (1996) Positional Cloning of the Mouse Retrovirus Restriction Gene Fv1. Nature 382, 826-829.
18. Bieniasz, P. D. (2004) Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5, 1109-1115.
19. Bishop, K. N.; Holmes, R. K.; Sheehy, A. M.; Davidson, N. O.; Cho, S. J. and Malim, M. H. (2004a) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396.
20. Bishop, K. N.; Holmes, R. K.; Sheehy, A. M. and Malim, M. H. (2004) APOBEC-mediated editing of viral RNA. Science 305, 645.
21. Bishop, N. and Woodman, P. (2001) TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J. Biol. Chem. 276, 11735-11742.
22. Bogerd, H. P.; Doehle, B. P.; Wiegand, H. L. and Cullen, B. R. (2004) From The Cover: A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101, 3770-3774.
23. Boone, L. R.;Innes, C. L. and Heitman, C. K. (1990) Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J. Virol. 64, 3376-3381.
24. Bouamr, F.; Melillo, J. A.; Wang, M. Q.; Nagashima, K.; de Los Santos, M. Rein, A. and Goff, S. P. (2003) PPPYEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101. J. Virol. 77, 11882-11895.
25. Braaten, D.; Franke, E. K. and Luban, J. (1996) Cyclophilin A Is Required for an Early Step in the Life Cycle of Human Immunodeficiency Virus Type 1 before the Initation of Reverse Transcription. J. Virol. 70, 3551-3560.
26. Cen, S.; Guo, F.; Niu, M.; Saadatmand, J.; Deflassieux, J. and Kleiman, L. (2004) The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 279, 33177-33184.
27. Chelbi-Alix, M. K.; Quignon, F.; Pelicano, L.; Koken, M. H. and de The, H. (1998) Resistance to virus infection conferred by the interferon-induced promyclocytic leukemia protein. J. Virol. 72, 1043-1051.
28. Chen, R.; Le Rouzic, E.; Kearney, J. A.; Mansky, L. M. and Benichou, S. (2004) Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J. Biol. Chem. 279, 28419-28425.
29. Chen, R.; Wang, H. and Mansky, L. M. (2002) Roles of uracil-DNA glycosylase and dUTPase in virus replication, J. Gen. Virol. 83, 2339-2345.
30. Chesebro, B. and Wehrly, K. (1979) Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA 76, 425-429.
31. Claas, C.; Stipp, C. S. and Hemler, M. E. (2001) Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J. Biol. Chem. 276, 7974-7984.
32. Cowan, S.; Hatziioannou, T.; Cunningham, T.; Muesing, M. A.; Gottlinger, H. G. and Bieniasz, P. D. (2002) Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99, 11914-11919.
33. Decleve, A.; Niwa, O.; Gelmann, E. and Kaplan, H. S. (1975) Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro. Virology 65, 320-332.
34. Demirov, D. G.; Ono, A., Orenstein, J. M. and Freed, E. O. (2002a) Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. USA 99, 955-960.
35. Demirov, D. G.; Orenstein, J. M. and Freed, E. O. (2002b) The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner. J. Virol. 76, 105-117.
36. Denzer, K.; Kleijmeer, M. J.; Heijnen, H. F.; Stoorvogel, W. and Geuze, H. J. (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113 Pt 19, 3365-3374.
37. DesGroseillers, L. and Jolicoeur, P. (1983) Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685-696.
38. Di Noia, J. and Neuberger, M. S. (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.
39. Duran-Troise, G.; Bassin, R. H.; Rein, A. and Gerwin, B. I. (1977) Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell 10, 479-488.
40. Eastman, S. W.; Martin-Serrano, J.; Chung, W.; Zang, T. and Bieniasz, P. D. (2005) Identification of human VPS37C, a component of ESCRT-1 important for viral budding. J. Biol. Chem. 280(1), 628-636, Epub 2004.
41. Escola, J. M., Kleijmeer, M. J.; Stoorvogel, W.; Griffith, J. M.; Yoshie, O. and Geuze, H. J. (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273, 20121-20127.
42. Franke, E. K.; Yuan, H. E. H. and Luban, J. (1994) Specific Incorporation of Cyclophilin A into HIV-1 virions. Nature 372, 359-362.
43. Freed, E. O. (2002) Viral late domains. J. Virol. 76, 4679-4687.
44. Futter, C. E.; Pearse, A.; Hewlett, L. J. and Hopkins, C. R. (1996) Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J. Cell Biol. 132, 1011-1023.
45. Gabuzda, D. H.; Lawrence, K.; Langhoff, E.; Terwilliger, E.; Dorfman, T.; Haseltine, W. A. and Sodroski, J. (1992) Role of vif in Replication of Human Immunodeficiency Virus Type 1 in CD4+ T Lymphocytes. J. Virol. 66, 6489-6495.
46. Gaddis, N. C.; Sheehy, A. M., Ahmad, K. M.; Swanson, C. M.; Bishop, K. N.; Beer, B. E.; Marx, P. A.; Gao, F.; Bibollet-Ruche, F.; Hahn, B. H. and Malim, M. H. (2004) Further investigation of simian immunodeficiency virus vif function in human cells. J. Virol. 78, 12041-12046.
47. Gardner, M.; Dandekar, S. and Cardiff, R. (1986) Molecular mechanism of an ecotropic MuLV restriction gene Akvr-1/FV-4 in California wild mice. Curr. Top Microbiol. Immunol. 127, 338-345.
48. Gardner, M. B.; Rasheed, S.; Pal, B. K.; Estes, J. D. and O'Brien, S. J. (1980) Akvr-1, a dominant murine leukemia virus restriction gene, is polymorphic in leukemia-prone wild mice. Proc. Natl. Acad. Sci. USA 77, 531-535.
49. Garrus, J. E.; von Schwedler, U. K.; Pornillos, O, W.; Morham, S. G.; Zavitz, K. H.; Wang, H. E.; Wettstein, D. A.; Stray, K. M.; Cote, M.; Rich, R. L.; Myszka, D. G. and Sundquist, W. I. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
50. Goff, S. P. (2004) Genetic control of retrovirus susceptibility in mammalian cells. Ann. Rev. Genet. 38, 61-85.
51. Goila-Gaur, R.; Demirov, D. G.; Orenstein, J. M.; Ono, A. and Freed, E. O. (2003) Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J. Virol. 77, 6507-6519.
52. Gottlinger, H. G.; Dorfman, T.; Sodroski, J. G. and Haseltine, W. A. (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88, 3195-3199.
53. Gottwein, E.; Bodem, J.; Muller, B.; Schmechel, A.; Zentgraf, H. and Krausslich, H. G. (2003) The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J. Virol. 77, 9474-9485.
54. Gould, S. J.; Booth, A. M. and Hildreth, J. E. (2003) The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA 100, 10592-10597.
55. Gruenberg, J. (2001) The endocytic pathway: a mosaic of domains. Nat, Rev. Mol. Cell Biol. 2, 721-730.
56. Gruenberg, J.; Griffiths, G. and Howell, K. E. (1989) Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J. Cell Biol. 108, 1301-1316.
57. Gruenberg, J. and Maxfield, F. R. (1995) Membrane transport in the endocytic pathway. Curr. Opin. Cell Biol. 7, 552-563.
58. Gruenberg, J. and Stenmark, H. (2004) The biogenesis of multivesicular endosomes. Nat. Rev. Mol. Cell Biol. 5, 317-323.
59. Harris, M. (1996) From Negative Factor to a Critical Role in Virus Pathogenesis: the Changing Fortunes of Nef. J. Gen. Virol. 77, 2379-2392.
60. Harris, R. S.; Bishop, K. N.; Sheehy, A. M.; Craig, H. M.; Petersen-Mahrt, S. K.; Watt, I. N.; Neuberger, M. S. and Malim, M. H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809.
61. Harris, R. S. and Liddament, M. T. (2004) Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4, 868-877.
62. Hartley, J. W.; Rowe, W. P. and Huebner, R. J. (1970) Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J. Virol. 5, 221-225.
63. Harty, R. N.; Brown, M. E.; Wang, G.; Huibregtse, J. and Hayes, F. P. (2000) A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. USA 97, 13871-13876.
64. Harty, R. N.; Paragas, J.; Sudol, M. and Palese, P. (1999) A proline-rich motif within the matrix protein of vesicular stomatitis Virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J. Virol. 73, 2921-2929.
65. Hatziioannou, T.; Cowan, S. and Bieniasz, P. D. (2004a) Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. J. Virol. 78, 1006-1011.
66. Hatziioannou, T.; Cowan, S.; Goff, S. P.; Bieniasz, P. D. and Towers, G. J. (2003) Restriction of multiple divergent retroviruses by Lv1 and Ref1. Embo J. 22, 385-394.
67. Hatziioannou, T.; Cowan, S.; Von Schwedler, U. K.; Sundquist, W. I. and Bieniasz, P. D. (2004b) Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol. 78, 6005-6012.
68. Hatziioannou, T.; Perez-Caballero, D.; Yang, A.; Cowan, S. and Bieniasz, P. D. (2004c) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. USA 101, 10774-10779.
69. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K. and Derse, D. (2004) Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J. Virol. 78, 6636-6648.
70. Heijnen, H. F.; Schiel, A. E.; Fijnheer, R.; Geuze, H. J. and Sixma, J. J. (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799.
71. Hierro, A.; Sun, J.; Rusnak, A. S.; Kim, J.; Prag, G.; Emr, S. D. and Hurley, J. H. (2004) Structure of the ESCRT-II endosomal trafficking complex. Nature 431, 221-225.
72. Hofmann, W,; Schubert, D.; LaBonte, J.; Munson, L.; Gibson, S.; Scammell, J.; Ferrigno, P. and Sodroski, J. (1999) Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028.
73. Huang, A. S.; Besmer, P.; Chu, L. and Baltimore, D. (1973) Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J. Virol. 12, 659-662.
74. Gag Is Required for Particle Production from Full-Length Human Immunodeficiency Virus Type 1 Molecular Clones Expressing Protease. J. Virol. 69, 6810-6818.
75. Ikeda, H. and Odaka, T. (1983) Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection. Virology 128, 127-139.
76. Ikeda, H. and Sugimura, H. (1989) Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J. Virol. 63, 5405-5412.
77. Imai, K.; Slupphaug, G.; Lee, W. I.; Revy, P.; Nonoyama, S.; Catalan, N.; Yel, L.; Forveille, M.; Kavli, B.; Krokan, H. E.; Ochs, H. D.; Fischer, A. and Durandy, A. (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4, 1023-1028.
78. Irie, T.; Licata, J. M.; McGettigan, J. P.; Schnell, M. J. and Harty, R. N. (2004) Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J. Virol. 78, 2657-2665.
79. Jarmuz, A.; Chester, A.; Bayliss, J.; Gisbourne, J.; Dunham, I.; Scott, J. and Navaratnam, N. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
80. Jayakar, H. R.; Murti, K. G. and Whitt, M. A. (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74, 9818-9827.
81. Johnstone, R. M.; Adam, M.; Hammond, J. R.; Orr, L. and Turbide, C. (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262, 9412-9420.
82. Jolicoeur, P. (1979) The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top Microbiol. Immunol. 86, 67-122.
83. Jolicoeur, P. and Baltimore, D. (1976) Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc. Natl. Acad. Sci. USA 73, 2236-2240.
84. Kanazawa, C.; Morita, E.; Yamada, M.; Ishii, N.; Miura, S.; Asao, H.; Yoshimori, T. and Sugamura, K. (2003) Effects of deficiencies of STAMs and Hrs, mammalian class E Vps proteins, on receptor downregulation. Biochem. Biophys. Res. Commun. 309, 848-856.
85. Kao, S.; Khan, M. A.; Miyagi, E.; Plishka, R.; Buckler-White, A. and Strebel, K. (2003) The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J. Virol. 77, 11398-11407.
86. Kao, S.; Miyagi, E.; Khan, M. A.; Takeuchi, H.; Opi, S.; Goila-Gaur, R. and Strebel, K. (2004) Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells. Retrovirology 1, 27.
87. Katzmann, D. J.; Babst, M. and Emr, S. D. (2001) Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-1. Cell 106, 145-155.
88. Katzmann, D. J.; Odorizzi, G. and Emr, S. D. (2002) Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3, 893-905.
89. Katzmann, D. J.; Stefan, C. J.; Babst, M. and Emr, S. D. (2003) Vps27 recruits ESCRT machinery to endosomes during MVB sorting. J. Cell Biol. 3, 413-423.
90. Keckesova, Z.; Ylinen, L. M. and Towers, G. J. (2004) The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. USA 101, 10780-10785.
91. Khan, M.; Jin, L.; Huang, M. B.; Miles, L.; Bond, V. C. and Powell, M. D. (2004) Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment. J. Virol. 78, 1843-1850.
92. Kikonyogo, A.; Bouamr, F.; Vana, M. L.; Xiang, Y.; Aiyar, A.; Carter, C. and Leis, J. (2001) Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA 98, 11199-11204.
93. Kobayashi, M.; Takaori-Kondo, A.; Shindo, K.; Abudu, A.; Fukunaga, K. and Uchiyama, T. (2004) APOBEC3G targets specific virus species. J. Virol. 78, 8238-8244.
94. Kobayashi, T.; Beuchat, M. H.; Lindsay, M.; Frias, S.; Palmiter, R. D; Sakuraba, H.; Parton, R. G. and Gruenberg, J. (1999) Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell Biol. 1, 113-118.
95. Kobayashi, T.; Gu, F. and Gruenberg, J. (1998) Lipids, lipid domains and lipid-protein interactions in endocytic membrane traffic. Semin. Cell Dev. Biol. 9, 517-526.
96. Kozak, C. A. and Chakraborti, A. (1996) Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance, Virology 225, 300-305.
97. Kozak, S. L.; Heard, J. M. and Kabat, D. (2002) Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76, 1802-1815.
98. Le Blanc, I.; Prevost, M. C., Dokhelar, M. C. and Rosenberg, A. R. (2002) The PPPY Motif of Human T-Cell Leukemia Virus Type 1 Gag Protein Is Required Early in the Budding Process. J. Virol. 76, 10024-10029.
99. Lecossier, D.; Bouchonnet, F.; Clavel, F. and Hance, A. J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protien. Science 300, 1112.
100. Lerner, D. L.; Wagaman, P. C.; Phillips, T. R.; Propero-Garcia, O; Henriksen, S. J.; Fox, H. S.; Bloom, F. E. and Elder, J. H. (1995) Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. USA 92, 7480-7484.
101. Licata, J. M.; Simpson-Holley, M.; Wright N. T.; Han, Z.; Paragas, J. and Harty, R. N.; (2003) Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function indepently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 77, 1812-1819.
102. Lichtenstein, D. L.; Rushlow, K. E.; Cook, R. F.; Raabe M. L.; Swardson, C. J.; Kociba, G. J.; Issel, C. J. and Montelaro, R. C. (1995) Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69, 2881-2888.
103. Liddament, M. T.; Brown, W. L.; Schumacher, A. J. and Harris. R. S. (2004) APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo. Curr. Biol. 14, 1385-1391.
104. Lilly, F. (1967) Susceptibility to two strains of Friend leukemia virus in mice. Science 155, 461-462.
105. Lilly, F. (1970) Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J. Natl. Cancer Inst. 45, 163-169.
106. Lindwasser, O. W. and Resh, M. D. (2004) Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies. J. Virol. 78, 6013-6023.
107. Lloyd, T. E.; Atkinson, R.; Wu, M. N.; Zhou, Y.; Pennetta, G. and Bellen, H. J. (2002) Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108, 261-269.
108. Lu, Q.; Hope, L. W.; Brasch, M.; Reinhard, C. and Cohen, S. N. (2003) TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc. Natl. Acad. Sci. USA 100, 7626-7631.
109. Luban, J.; Bossolt, K. L.; Franke, E. K.; Kalpana, G. V. and Goff, S. P. (1993) Human Immunodeficiency Virus Type 1 Gag Protein Binds to Cyclophilins A and B. Cell 73, 1067-1078.
110. Luo, K.; Liu, B.; Xiao, Z.; Yu, Y.; Yu, X.; Gorelick, R. and YU, X. F. (2004) Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging. J. Virol. 78, 11841-11852.
111. Lusa, S.; Blom, T. S.; Eskelinen, E. L.; Kuismanen, E.; Mansson, J. E.; Simons, K. and Ikonen, E. (2001) Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J. Cell Sci. 114. 1893-1900.
112. MacGinnitie, A. J.; Anant, S. and Davidson, N. O. (1995) Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J. Biol. Chem. 270, 14768-14775.
113. Madani, N. and Kabat, D. (1998) An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255.
114. Mangeat, B.; Turelli, P.; Caron, G.; Friedli, M.; Perrin, L. and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
115. Mangeat, B.; Turelli, P.; Liao, S. and Trono, D. (2004) A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279, 14481-14483.
116. Mansky, L. M.; Preveral, S.; Selig, L.; Benarous, R. and Benichou, S. (2000) The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J. Virol. 74, 7039-7047.
117. Mariani, R.; Chen, D.; Schrofelbauer, B.; Navarro, F.; Konig, R.; Bollman, B.; Munk, C.; Nymark-McMahon, H. and Landau, N. R. (2003) Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif. Cell 114, 21-31.
118. Marin, M.; Rose, K. M.; Kozak, S. L. and Kabat, D. (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398-1403.
119. Martin-Serrano, J. and Bieniasz, P. D. (2003) A bipartite late-budding domain in human immunodeficiency virus type 1. J. Virol. 77, 12373-12377.
120. Martin-Serrano, J.; Perez-Caballero, D. and Bieniasz, P. D. (2004) Context-dependent effects of L domains and ubiquitination on viral budding. J. Virol. 78, 5554-5563.
121. Martin-Serrano, J.; Yaravoy, A.; Perez-Caballero, D. and Bieniasz, P. D. (2003a) Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. USA 100, 12414-12419.
122. Martin-Serrano, J.; Zang, T. and Bieniasz, P. D. (2001) HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313-1319.
123. Martin-Serrano, J.; Zang, T. and Bieniasz, P. D. (2003b) Role of ESCRT-1 in retroviral budding. J. Virol. 77, 4794-4804.
124. Mayran, N.; Parton, R. G. and Gruenberg, J. (2003) Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. Embo J. 22, 3242-3253.
125. McKnight, A.; Dittmar, M. T.; Moniz-Periera, J.; Ariyoshi, K.; Reeves, J. D.; Hibbitts, S.; Whitby, D.; Aarons, E.; Proudfool, A. E.; Whittle, H. and Clapham, P. R. (1998) A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J. Virol. 72, 4065-4071.
126. McKnight, A.; Griffiths, D. J.; Dittmar, M.; Clapham, P. and Thomas, E. (2001) Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. J. Virol. 75, 6914-6922.
127. Mehle, A.; Goncalves, J.; Santa-Marta, M.; McPike, M. and Gabuzda, D. (2004a) Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cu15 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861-2866.
128. Mehle, A.; Strack, B.; Ancuta, P.; Zhang, C.; McPike, M. and Gabuzda, D. (2004b) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279, 7792-7798.
129. Mobius, W.; Ohno-Iwashita, Y.; van Donselaar, E. G.; Oorschot, V, M.; Shimada, Y., Fujimoto, T.; Heijnen, H. F.; Geuze, H. J. and Slot, J. W. (2002) Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J. Histochem. Cytochem. 50, 43-55.
130. Morita, E. and Sundquist, W. I. (2004) Retrovirus Budding. Ann. Rev. Cell Dev. Biol. 20, 395-425.
131. Morrison, R. P.; Nishio, J. and Chesebro, B. (1986) Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J. Exp. Med. 163, 301-314.
132. Narayan, S. and Young, J. A. (2004) Reconstitution of retroviral fusion and uncoating in a cell-free system. Proc. Natl. Acad. Sci. USA 101, 7721-7726.
133. Nguyen, D. G.; Booth, A.; Gould, S. J. and Hildreth, J. E. (2003) Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278, 52347-52354.
134. Nisole, S.; Lynch, C.; Stoye, J. P. and Yap, M. W. (2004) A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA 101, 13324-13328.
135. Odaka, T. and Yamamoto, T. (1965) Inheritance of susceptibility to Friend mouse leukemia virus. 11. Spleen foci method applied to test the susceptibility of crossbred progeny between a sensitive and a resistant Strain. Jpn. J. Exp. Med. 35, 311-314.
136. Ono, A. and Freed, E. O. (2004) Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78, 1552-1563.
137. Ott, D. E.; Coren, L. V.; Chertova, E. N.; Gagliardi, T. D. and Schubert, U. (2000) Ubiquitination of HIV-1 and MuLV Gag. Virology 278, 111-121.
138. Ott, D. E.; Coren, L. V.; Sowder, R. C. 2nd; Adams, J.; Nagashima, K. and Schubert, U. (2002) Equine infectious anemia virus and the ubiquitin-proteasome system. J. Virol. 76, 3038-3044.
139. Ott, D. E.; Coren, L. V.; Sowder, R. C. 2nd; Adams, J. and Schubert, U. (2003) Retroviruses have differing requirements for proteasome function in the budding process. J. Virol. 77, 3384-3393.
140. Ou, C. Y.; Boone, L. R.; Koh, C. K.; Tennant, R. W. and Yang, W. K. (1983) Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses. J. Virol. 48, 779-784.
141. Owens, C. M.; Song, B.; Perron, M. J.; Yang, P. C.; Stremlau, M. and Sodroski, J. (2004) Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. 78, 5423-5437.
142. Pan, B. T. and Johnstone, R. M. (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967-978.
143. Parent, L. J.; Bennett, R. P.; Craven, R. C.; Nelle, T. D.; Krishna, N. K.; Bowzard, J. B.; Wilson, C. B.; Puffer, B. A.; Montelaro, R. C. and Wills, J. W. (1995) Positionally Independent and Exchangeable Late Budding Functions of the Rous Sarcoma Virus and Human Immunodeficiency Virus Gag Proteins. J. Virol. 69, 5455-5460.
144. Patnaik, A.; Chau, V.; Li, F.; Montelaro, R. C. and Wills, J. W. (2002) Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J. Virol. 76, 2641-2647.
145. Patnaik, A.; Chau, V. and Wills, J. W. (2000) Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA 97, 13069-13075.
146. Pelchen-Matthews, A.; Kramer, B. and Marsh, M. (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-455.
147. Perron, M. J.; Stremlau, M.; Song, B.; Ulm, W.; Mulligan, R. C. and Sodroski, J. (2004) TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. USA 101, 11827-11832.
148. Peters, P. J.; Geuze, H. J.; Van der Donk, H. A.; Slot, J. W.; Griffith, J. M.; Stam, N. J.; Clevers, H. C. and Borst, J. (1989) Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur. J. Immunol. 19, 1469-1475.
149. Petersen-Mahrt, S. K.; Harris, R. S. and Neuberger, M. S. (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibodv diversification. Nature 418, 99-103.
150. Pincus, T.; Hartley, J. W. and Rowe, W. P. (1975) A major genetic locus affecting resistance to infection with murine leukemia viruses, IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures. Virology 65, 333-342.
151. Pincus, T.; Rowe, W. P. and Lilly, F. (1971) A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend marine leukemia virus. J. Exp. Med. 133, 1234-1241.
152. Piper, R. C. and Luzio, J. P. (2001) Late endosomes: sorting and partitioning in multivesicular bodies. Traffic 2, 612-621.
153. Pornillos, O.; Alam, S. L.; Davis, D. R. and Sundquist, W. I. (2002) Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9, 812-817.
154. Pornillos, O.; Higginson, D. S.; Stray, K. M.; Fisher, R. D.; Garrus, J. E.; Payne, M.; He, G. P.; Wang, H. E.; Morham, S. G. and Sundquist, W. I. (2003) HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J. Cell. Biol. 162, 425-434.
155. Pryciak, P. M. and Varmus, H. E. (1992) Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol. 66, 5959-5966.
156. Puffer, B, A.; Parent, L. J.; Wills, J. W. and Montelaro, R. C. (1997) Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71, 6541-6546.
157. Putterman, D.; Pepinsky, R. B. and Vogt, V. M. (1990) Ubiquitin in avian leukosis virus particles. Virology 176, 633-637.
158. Quaderi, N. A.; Schweiger, S.; Gaudenz, K.; Franco, B.; Rugarli, E. I.; Berger, W.; Feldman, G. J.; Volta, M.; Andolfi, G.; Gilgenkrantz, S.; Marion, R. W.; Hennekam, R. C.; Opitz, J. M.; Muenke, M,; Ropers, H. H. and Ballabio, A. (1997) Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet. 17, 285-291.
159. Rada, C.; Williams, G. T.; Nilsen, H.; Barnes, D. E.; Lindahl, T. and Neuberger, M. S. (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748-1755.
160. Raposo, G.; Moore, M.; Innes, D.; Leijendekker, R.; Leigh-Brown, A.; Benaroch, P. and Geuze, H. (2002) Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718-729.
161. Raposo, G.; Nijman, H. W.; Stoorvogel, W.; Liejendekker, R.; Harding, C. V.; Melief, C. J. and Geuze, H. J. (1996) B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172.
162. Raposo, G.; Tenza, D.; Mecheri, S.; Peronet, R.; Bonnerot, C. and Desaymard, C. (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation, Mol. Biol. Cell 8, 2631-2645.
163. Rasheed, S. and Gardner, M. B. (1983) Resistance to fibroblasts and hematopoietic cells to ecotropic murine leukemia virus infection; an Akvr-1R gene effect. Int. J. Cancer 31, 491-496.
164. Reggiori, F. and Pelham, H. R. (2001) Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. Embo J. 20, 5176-5186.
165. Reymond, A.; Meroni, G.; Fantozzi, A.; Merla, G.; Cairo, S.; Luzi, L.; Riganelli, D.; Zanaria, E.; Messali, S.; Cainarca, S.; Guffanti, A.; Minucci, S.; Pelicci, P. G. and Ballabio A. (2001) The tripartite motif family identifies cell compartments. Embo J. 20, 2140-2151.
166. Rieu, S.; Geminard, C.; Rabesandratana, H.; Sainte-Marie, J. and Vidal, M. (2000) Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur. J. Biochem. 267, 583-590.
167. Rose, K. M.; Marin, M.; Kozak, S. L. and Kabat, D. (2004) Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J. Biol. Chem. 279, 41744-41749.
168. Rose, K. M.; Marin, M.; Kozak, S. L. and Kabat, D. (2004b) The viral infectivity factor (Vif) of HIV-1 unveiled. Trends Mol. Med. 10, 291-297.
169. Rosler, C.; Kock, J.; Malim, M. H.; Blum, H. E. and von Weizsacker, F. (2004) Comment on "Inhibition of hepatitis B virus replication by APOBEC3G". Science 305, 1403; author reply 1403.
170. Rothman, J. H.; Yamashiro, C. T.; Kane, P. M. and Stevens, T. H. (1989) Protein targeting to the yeast vacuole. Trends Biochem. Sci. 14, 347-350.
171. Rowe, W. P.; Humphrey, J. B. and Lilly, F. (1973) A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J. Exp. Med. 137, 850-853.
172. Sawyer, S. L.; Emerman, M. and Malik, H. S. (2004) Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G. PLoS Biol. 2, E275.
173. Sayah, D. M. and Luban, J. (2004) Selection for Loss of Ref1 Activity in Human Cells Releases Human Immunodeficiency Virus Type 1 from Cyclophilin A Dependence during Infection. J. Virol. 78, 12066-12070.
174. Sayah, D. M.; Sokolskaja, E.; Berthoux, L. and Luban, J. (2004) Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573.
175. Schmitz, C.; Marchant, D.; Neil, S. J.; Aubin, K.; Reuter, S.; Dittmar, M. T. and McKnight, A. (2004) Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78, 2006-2016.
176. Schrofelbauer, B.; Chen, D. and Landau, N. R. (2004) From The Cover: A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101, 3927-3932.
177. Schubert, U.; Ott, D. E.; Chertova, E. N., Welker, R.; Tessmer, U.; Princiotta, M. F.; Bennink, J. R.; Kräusslich, H.-G. and Yewdell, J. W. (2000) Proteasome inhibition interferes with Gag polprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. USA 97, 13057-13062.
178. Schwartz, O.; Marechal, V.; Friguet, B.; Arenzana-Seisdedos, F. and Heard, J. M. (1998) Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72, 3845-3850.
179. Serhan, F.; Jourdan, N.; Saleun, S.; Moullier, P. and Duisit, G. (2002) Characterization of producer cell-dependent restriction of murine leukemia virus replication. J. Virol. 76, 6609-6617.
180. Sheehy, A. M.; Gaddis, N. C.; Choi, J. D. and Malim, M. H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
181. Sheehy, A. M.; Gaddis, N. C. and Malim, M. H. (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404-1407.
182. Shehu-Xhilaga, M.; Ablan, S.; Demirov, D. G.; Chen, C. Montelaro, R. C. and Freed, E. O. (2004) Late Domain-Dependent Inhibition of Equine Infectious Anemia Virus Budding. J. Virol. 78, 724-732.
183. Simon, J. H.; Gaddis, N. C.; Fouchier, R. A. and Malim, M. H. (1998a) Evidence for a newly discovered cellular anti-HIV-1 phenotype, Nat. Med. 4, 1397-1400.
184. Simon, J. H. M. and Malim, M. H. (1996) The Human Immunodeficiency Virus Type 1 Vif Protein Modulates the Postpenetration Stability of Viral Nucleoprotein Complexes. J. Virol. 70, 5297-5305.
185. Simon, J. H. M.; Miller, D. L.; Fouchier, R. A. M.; Soares, M. A.; Peden, K.W. C. and Malim, M. H. (1998b) The Regulation of Primate Immunodeficiency Virus Infectivity by Vif Is Cell Species Restricte: A Role for Vif in Determining Virus Host Range and Cross-Species Transmission. EMBO J. 17, 1259-1267.
186. Sova, P. and Volsky, D. J. (1993) Efficiency of Viral DNA Synthesis During Infection of Permissive and Nonpermissive Cells with vif-Negative Human Immundeficiency Virus Type 1. J. Virol. 67, 6322-6326.
187. Spidel, J. L.; Craven, R. C.; Wilson, C. B.; Patnaik, A.; Wang, H.; Mansky, L. M. and Wills, J. W. (2004) Lysines close to the tons sarcoma virus late domain critical for budding. J. Virol. 78, 10606-10616.
188. Stack, J. H.; Horazdovsky, B. and Emr, S. D. (1995) Receptor-mediated protein sorting to the vacuole in yeast: roles for a protein kinase, a lipid kinase and GTP-binding proteins. Ann. Rev. Cell Dev. Biol. 11, 11-33.
189. Stopak, K.; de Noronha, C.; Yonemoto, W. and Greene, W. C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601.
190. Strack, B.; Calistri, A.; Accola, M. A.; Palù, G. and Göttlinger, H, (2000) A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA 97, 13063-13068.
191. Strack, B.; Calistri, A.; Craig, S.; Popova, E. and Gottlinger, H. G. (2003) AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding. Cell 114, 689-699.
192. Stremlau, M.; Owens, C. M.; Perron, M. J.; Kiessling, M.; Autissier, P. and Sodroski, J. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
193. Stuchell, M. D.; Garrus, J. E.; Muller, B.; Stray, K. M.; Ghaffarian, S.; McKinnon, R.; Krausslich, H. G.; Morham, S. G. and Sundquist, W. I. (2004) The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding. J. Biol. Chem. 279, 36059-36071.
194. Sundquist, W. I.; Schubert, H. L.; Kelly, B. N.; Hill, G. C.; Holton, J. M. and Hill, C. P. (2004) Ubiquitin Recognition by the Human TSG101 Protein. Mol. Cell 13, 783-789.
195. Suspene, R.; Sommer, P.; Henry, M.; Ferris, S.; Guetard, D.; Pochet, S.; Chester, A.; Navaratnam, N.; Wain-Hobson, S. and Vartanian, J. P. (2004) APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32, 2421-2429.
196. Suzuki, S. (1975) FV-4: a new gene affecting the splenomegaly induction by Friend leukemia virus. Jpn J. Exp. Med. 45, 473-478.
197. Svarovskaia, E. S.; Xu, H.; Mbisa, J. L.; Barr, R.; Gorelick, R. J.; One, A. Freed, E. O.; Hu, W. S. and Pathak, V. K. (2004) Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs. J. Biol. Chem. 279, 35822-35828.
198. Takeuchi, H.; Kao, S.; Miyagi, E.; Khan, M. A.; Buckler-White, A.; Plishka, R. and Strebel, K. (2005) Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G. J. Biol. Chem. 280(1), 375-382, Epub 2004.
199. Tanzi, G. O.; Piefer, A. J. and Bates, P. (2003) Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release. J. Virol. 77, 8440-8447.
200. Teng, B.; Burant, C. F. and Davidson, N. O. (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819.
201. Tennant, R. W.; Otten, J. A.; Brown, A.; Yang, W. K. and Kennel, S. J. (1979) Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics. Virology 99, 349-357.
202. Thali, M.; Bukovsky, A.; Kondo, E.; Rosenwirth, B.; Walsh, C. T.; Sodroski, J. and Göttlinger, H. G. (1994) Functional Association of Cyclophilin A with HIV-1 Virions. Nature 372, 363-365.
203. Towers, G.; Bock, M.; Martin, S.; Takeuchi, Y.; Stoye, J. P. and Danos, O. (2000) A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA 97, 12295-12299.
204. Towers, G.; Collins, M. and Takeuchi, Y. (2002) Abrogation of Ref1 retrovirus restriction in human cells. J. Virol. 76, 2548-2550.
205. Towers, G. J.; Hatziioannou, T.; Cowan, S.; Goff, S. P.; Luban, J. and Bieniasz, P. D. (2003) Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9, 1138-1143.
206. Turelli, P.; Doucas, V.; Craig, E.; Mangeat, B.; Klages, N.; Evans, R.; Kalpana, G. and Trono, D. (2001) Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7, 1245-1254.
207. Turelli, P.; Guiguen, F.; Mornex, J. F.; Vigne, R. and Querat, G. (1997) dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J. Virol. 71, 4522-4530.
208. Turelli, P.; Jost, S.; Mangeat, B. and Trono, D. (2004a) Response to Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G". Science 305, 1403B.
209. Turelli, P.; Mangeat, B.; Jost, S.; Vianin, S. and Trono, D. (2004b) Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829.
210. Turelli, P.; Petursson, G.; Guiguen, F.; Mornex, J. F.; Vigne, R. and Querat, G. (1996) Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70, 1213-1217.
211. Turelli, P.; Vianin, S. and Trono, D. (2004c) The Innate Antiretroviral Factor APOBEC3G Does Not Affect Human LINE-1 Retrotransposition in a Cell Culture Assay. J. Biol. Chem. 279, 43371-43373.
212. Urbanowski, J. L. and Piper, R. C. (2001) Ubiquitin sorts proteins into the intralumenal degradative compartment of the late-endosome/vacuole. Traffic 2, 622-630.
213. van Deurs, B.; Holm, P. K.; Kayser, L.; Sandvig, K. and Hansen, S. H. (1993) Multivesicular bodies in HEp-2 cells are maturing endosomes. Eur. J. Cell Biol. 61, 208-224.
214. VerPlank, L.; Bouamr, F.; LaGrassa, T. J.; Agresta, B.; Kikonyogo, A.; Leis, J. and Carter, C. A. (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98, 7724-7729.
215. Vidal, M. J. and Stahl, P. D. (1993) The small GTP-binding proteins Rab4 and ARF are associated with released exosomes during reticulocyte maturation. Eur. J. Cell Biol. 60, 261-267.
216. von Schwedler, U.; Song, J.; Aiken, C. and Trono, D. (1993) Vif Is Crucial for Human Immunodeficiency Virus Type 1 Proviral DNA Synthesis in Infected Cells. J. Virol. 67, 4945-4955.
217. von Schwedler, U. K.; Stuchell, M.; Muller, B.; Ward, D. M.; Chung, H. Y.; Morita, E.; Wang, H. E.; Davis, T.; He, G. P.; Cimbora, D. M.; Scott, A.; Krausslich, H. G.; Kaplan, J.; Morham, S. G. and Sundquist, W. I. (2003) The Protein Network of HIV Budding. Cell 114, 701-713.
218. Wang, H.; Machesky, N. J. and Mansky, L. M. (2004) Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. J. Virol. 78, 1503-1512.
219. Waterman, H.; Levkowitz, G.; Alroy, I. and Yarden, Y. (1999) The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274, 22151-22154.
220. Wedekind, J. E.; Dance, G. S.; Sowden, M. P. and Smith, H. C. (2003) Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 19, 207-216.
221. Wiegand, H. L.; Doehle, B. P.; Bogerd, H. P. and Cullen, B. R. (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. Embo J. 23, 2451-2458.
222. Xu, H.; Svarovskaia, E. S.; Barr, R.; Zhang, Y.; Khan, M. A.; Strebel, K. and Pathak, V. K. (2004) A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA 101, 5652-5657.
223. Xu, L.; Yang, L.; Moitra, P. K.; Hashimoto, K.; Rallabhandi, P.; Kaul, S.; Meroni, G.; Jensen, J. P.; Weissman, A. M. and D'Arpa, P. (2003) BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp. Cell Res. 288, 84-93.
224. Yang, W. K.; Kiggans, J. O.; Yang, D. M.; Ou, C. Y.; Tennant, R. W.; Brown, A. and Bassin, R. H. (1980) Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells. Proc. Natl. Acad. Sci. USA 77, 2994-2998.
225. Yap, M. W.; Nisole, S.; Lynch, C. and Stoye, J. P. (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. USA 101, 10786-10791.
226. Yoshikura, H. (1975) Adaptation of N-tropic Friend leukaemia virus and its murine sarcoma virus pseudotype of non-permissive B-type C57BL/6 mouse cell line. J. Gen. Virol. 29, 1-9.
227. Yu, Q.; Chen, D. Konig, R.; Mariani, R.; Unutmaz, D. and Landau, N. R. (2004a) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279, 53379-53386.
228. Yu, Q.; Konig, R.; Pillai, S.; Chiles, K.; Kearney, M.; Palmer, S.; Richman, D.; Coffin, J. M. and Landau, N. R. (2004b) Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11, 435-442.
229. Yu, X.; Yu, Y.; Liu, B., Luo, K.; Kong, W.; Mao, P. and Yu, X. F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
230. Yu, Y.; Xiao, Z.; Ehrlich, E. S.; Yu, X. and Yu, X. F. (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18, 2867-2872.
231. Yuan, B.; Campbell, S.; Bacharach, E.; Rein, A. and Goff, S. P. (2000) Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74, 7250-7260.
232. Zennou, V.; Perez-Caballero, D.; Gottlinger, H. and Bieniasz, P. D. (2004) APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles. J. Virol. 78, 12058-12061.
233. Zhang, H.; Yang, B.; Pomerantz, R. J.; Zhang, C.; Arunachalam, S. C. and Gao, L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98.
234. Zheng, Y. H.; Irwin, D.; Kurosu, T.; Tokunaga, K.; Sata, T. and Peterlin, B. M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076.
235. Zitvogel, L.; Regnault, A.; Lozier, A.; Wolters, J.; Flament, C.; Tenza, D.; Ricciardi-Castagnoli, P.; Raposo, G. and Amigorena, S. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600.